/

PCLO.V

PHARMACIELO LTDOpen

0.05000.00 0.00%CAD

TSXV · as of Oct 14, 10:08 ET

Open

0.0500

Prev close

0.0500

Day range

0.05000.0500

52-week range

0.03500.1650

Volume

94.00K1.48×

Mkt cap

10.01M

P/E ttm

—

Fwd P/E

-1.00

EPS ttm

-0.0200

Div yield

0.00%

Earnings

Jul 30, 2026

From 52w high

−69.70%

Price Chart

Yahoo Finance · delayed

PCLO.VOct 14, 2026O 0.0500H 0.0500L 0.0500C 0.05000.0000 (0.00%)Vol 94.00K

SMA 500.0585
SMA 2000.0673

1Y change +11.11% since Oct 10, 2025 close540 bars loadedTimes in America/TorontoDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

PCLO.V PHARMACIELO LTD · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −16.67%
1 month: −16.67%
3 months: −23.08%
6 months: +11.11%
Year to date: +11.11%
1 year: +11.11%

Valuation & ownership

Market cap: 10.01M
Enterprise value: 29.19M
P/E (ttm): —
Forward P/E: -1.00
PEG ratio: —
Price / book: —
Price / sales (ttm): 2.78
EV / EBITDA: -15.30
EPS (ttm): -0.0200
EPS (forward): -0.0500
Beta (5y monthly): 0.62
Dividend yield: 0.00%
Payout ratio: —
Shares outstanding: 200.14M
Float: 189.43M
Short % of float: —
Short ratio (days): 0.67
Held by insiders: 12.93%
Held by institutions: 0.14%
Avg volume (3m): 63.62K
50-day average: 0.0590
200-day average: 0.0672
52-week change: +11.11%
S&P 500 52-week: +17.00%

Technicals (daily)

RSI (14): 39.8
vs 50-day SMA: −14.53%
vs 200-day SMA: −25.65%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▼ below
ATR (14) % of price: 7.93%
Realised vol (20d, ann.): 82.6%
From 52-week high: −69.70%
From 52-week low: +42.86%

ANR

Analyst Consensus

No analyst coverage for this instrument.

Financial Snapshot

Full statements →trailing twelve months

Revenue (ttm): 3.60M
Revenue growth (yoy): +331.00%
Earnings growth (yoy): —
Gross margin: 36.19%
Operating margin: -48.22%
Profit margin: -103.08%

DES

About PHARMACIELO LTD

Yahoo Finance profile

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. It offers medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. PharmaCielo Ltd. is headquartered in Toronto, Canada.

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Headquarters: Toronto, ON, Canada
Website: pharmacielo.com
Officers: Mr. Marc Lustig M.B.A., M.Sc. Chairman & CEO
Mr. Ian D. Atacan B.Sc., C.M.A., C.P.A., M.B.A. CFO, Corporate Secretary & Director
Mr. Andres Felipe Botero Chief Operating Officer
Dr. Decio Rabelo de Castro Filho Chief Medical Officer

SEAS

Seasonality · PCLO.V

2019–2026 · monthly returns

Strongest month Sep +8.94%Weakest month May −18.50%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	100.0	-44.4	-20.0	25.0	70.0	-23.5	15.4	-20.0	-8.3	-9.1			+11.1%
2025	12.5	-11.1	-18.8	7.7	-35.7	44.4	-15.4	-18.2	0.0	0.0	0.0	0.0	−43.7%
2024	2.8	-8.1	20.6	-12.2	-13.9	0.0	-9.7	-21.4	63.6	-44.4	-15.0	-5.9	−55.6%
2023	45.7	-5.9	-2.1	-14.9	-10.0	11.1	-25.0	20.0	11.1	-5.0	-10.5	5.9	+2.9%
2022	0.0	-7.1	-23.1	-11.4	-25.0	-6.5	14.9	-10.0	-2.2	-11.4	-20.5	-43.5	−82.1%
2021	-12.5	33.0	-24.4	-13.1	-10.1	-7.7	15.9	-20.9	9.9	-22.6	-11.7	7.7	−52.9%
2020	-4.9	-33.1	-55.7	22.1	-15.2	-21.3	-17.1	5.2	-25.4	38.5	106.3	60.0	−31.8%
2019				-9.4	-19.6	-3.7	-36.8	13.8	5.6	-44.4	4.6	2.3	−68.4%

INSD

Insider Activity · PCLO.V

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Oct 8, 2026	Bache (Douglas)Director of Issuer	Acquisition in the public market at price 0.04 per share.	41K	$1.60K
Oct 7, 2026	Bache (Douglas)Director of Issuer	Acquisition in the public market at price 0.04 per share.	350K	$14.70K
Oct 6, 2026	Bache (Douglas)Director of Issuer	Acquisition in the public market at price 0.04 per share.	72K	$2.81K
Oct 6, 2026	Bache (Douglas)Director of Issuer	Acquisition in the public market at price 0.04 per share.	50K	$2.10K
Oct 4, 2026	Bache (Douglas)Director of Issuer	Acquisition in the public market at price 0.04 per share.	100K	$4.20K
Aug 31, 2026	Bache (Douglas)Director of Issuer	Disposition in the public market at price 0.04 per share.	70K	$2.80K
Mar 15, 2026	Atacan, Ian DDirector of Issuer	Acquisition carried out privately at price 0.06 per share.	136.4K	$7.91K
Mar 15, 2026	Lustig (Marc)Director of Issuer	Acquisition carried out privately at price 0.06 per share.	2.53M	$146.72K
Mar 15, 2026	Lustig (Marc)Director of Issuer	Acquisition carried out privately at price 0.06 per share.	453.4K	$26.30K
Mar 15, 2026	Petron (William Boris)Director of Issuer	Acquisition carried out privately at price 0.06 per share.	767.1K	$44.49K

PCLO.V

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

PCLO.V

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About PHARMACIELO LTD

Seasonality · PCLO.V

Insider Activity · PCLO.V

Congress Trades · PCLO.V

Investors Holding PCLO.V

Investors Holding PCLO.V

Congress Trades · PCLO.V

Seasonality · PCLO.V

Insider Activity · PCLO.V

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About PHARMACIELO LTD

Earnings & Dividends

News